SHINE submits application for isotope plant to NRC

03/31/2013 | Wisconsin State Journal (Madison)

SHINE Medical Technologies in Monona, Wis., said it has submitted an application to the Nuclear Regulatory Commission for the establishment of a medical isotope facility in Janesville, Wis., that will produce molybdenum-99, the precursor isotope to technetium-99m. The company said it anticipates the review of its plan will take 18 months. SHINE wants to start production by 2015 and projects to create at least 150 jobs.

View Full Article in:

Wisconsin State Journal (Madison)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA